Quality of life analyses in patients with multiple myeloma: results from the Selinexor (KPT-330) Treatment of Refractory Myeloma (STORM) phase 2b study

Authors: Gabriel Tremblay, Patrick Daniele, Janis Breeze, Lingling Li, Jatin Shah, Sharon Shacham, Michael Kauffman, Monika Engelhardt, Ajaj Chari, Ajay Nooka, Dan Vogl, Maria Gavriatopoulou, Meletios-Athanasios Dimopoulos, Paul Richardson, Noa Biran, David Siegel, Philip Vlummens, Chantal Doyen, Thierry Facon, Mohamad Mohty, Nathalie Meuleman, Moshe Levy, Luciano Costa, James E. Hoffman, Michel Delforge, David Kaminetzky, Katja Weisel, Marc Raab, David Dingli, Sascha Tuchman, Frenzel Laurent, Ravi Vij, Gary Schiller, Philippe Moreau, Joshua Richter, Martin Schreder, Klaus Podar, Terri Parker, Robert Frank Cornell, Karlin Lionel, Sylvain Choquet, Jagannath Sundar

Source: BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)

Subject Terms: Patient reported outcomes, Health-related quality of life, FACT-MM, Multiple myeloma, Selinexor, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/1471-2407

Access URL: https://doaj.org/article/ad0d07b841e64c82afc2fcdee19751cf

Safety and activity of talquetamab in patients with relapsed or refractory multiple myeloma (MonumenTAL-1): a multicentre, open-label, phase 1–2 study

Authors: Chari, Ajai ^{a, *}, Touzeau, Cyrille ^b, Schinke, Carolina ^c, Minnema, Monique C ^d, Berdeja, Jesus G ^e, Oriol, Albert ^f, van de Donk, Niels W C J ^g, Rodríguez-Otero, Paula ^h, Morillo, Daniel ⁱ, Martinez-Chamorro, Carmen ^j, Mateos, María-Victoria ^k, Costa, Luciano J ^l, Caers, Jo ^m, Rasche, Leo ⁿ, Krishnan, Amrita ^o, Ye, Jing Christine ^p, Karlin, Lionel ^q, Lipe, Brea ^r, Vishwamitra, Deeksha ^s, Skerget, Sheri ^s, Verona, Raluca ^s, Ma, Xuewen ^s, Qin, Xiang ^s, Ludlage, Hein ^t, Campagna, Michela ^u, Masterson, Tara ^s, Hilder, Brandi ^s, Tolbert, Jaszianne ^s, Renaud, Thomas ^v, Goldberg, Jenna D ^v, Kane, Colleen ^s, Heuck, Christoph ^s, San-Miguel, Jesus ^h, Moreau, Philippe ^b

Source: In The Lancet Haematology April 2025 12(4):e269-e281

Isatuximab, carfilzomib, lenalidomide, and dexamethasone induction in newly diagnosed myeloma: analysis of the MIDAS trial

Authors: Perrot, Aurore ^{1, ∗}, Touzeau, Cyrille ², Lambert, Jerome ³, Hulin, Cyrille ⁴, Caillot, Denis ⁵, Karlin, Lionel ⁶, Arnulf, Bertrand ⁷, Rey, Philippe ⁸, Garderet, Laurent ⁹, Macro, Margaret ¹⁰, Escoffre Barbe, Martine ¹¹, Gay, Julie ¹², Chalopin, Thomas ¹³, Gounot, Romain ¹⁴, Schiano, Jean-Marc ¹⁵, Tiab, Mourad ¹⁶, Mohty, Mohamad ¹⁷, Kuhnowski, Frederique ¹⁸, Fontan, Jean ¹⁹, Manier, Salomon ²⁰, Orsini-Piocelle, Frederique ²¹, Vincent, Laure ²², Rigaudeau, Sophie ²³, Leleu, Xavier ²⁴, Hebraud, Benjamin ¹, Flet, Laurent ²⁵, Malfuson, Jean-Valere ²⁶, Jacquet, Caroline ²⁷, Chaoui, Driss ²⁸, Meuleman, Nathalie ²⁹, Abarah, Wajed ³⁰, Montes, Lydia ³¹, Benramdane, Riad ³², Sonntag, Cecile ³³, Zerazhi, Hacene ³⁴, Danu, Alina ³⁵, Allangba, Olivier ³⁶, Dib, Mamoun ³⁷, Roussel, Murielle ³⁸, Cereja, Sophie ³⁹, Depaus, Julien ⁴⁰, Branche, Nicolas ⁴¹, Demarquette, Helene ⁴², Richez, Valentine ⁴³, Cherel, Brieuc ⁴⁴, Frenzel, Laurent ⁴⁵, Vekemans, Marie-Christiane ⁴⁶, Bigot, Noemie ³, Avet-Loiseau, Herve ⁴⁷, Corre, Jill ⁴⁷, Moreau, Philippe ²

Source: In Blood December 2024

Efficacy and safety of teclistamab in patients with relapsed/refractory multiple myeloma after BCMA-targeting therapies

Authors: Touzeau, Cyrille, Krishnan, Amrita Y., Moreau, Philippe, Perrot, Aurore, Usmani, Saad Z., Manier, Salomon, Cavo, Michele, Martinez Chamorro, Carmen, Nooka, Ajay K., Martin, Thomas G., Karlin, Lionel, Leleu, Xavier, Bahlis, Nizar J., Besemer, Britta, Pei, Lixia, Stein, Sarah, Wang Lin, Shun Xin, Trancucci, Danielle, Verona, Raluca I., Girgis, Suzette, Miao, Xin, Uhlar, Clarissa M., Chastain, Katherine, Garfall, Alfred L.

Source: In Blood 5 December 2024 144(23):2375-2388

Bortezomib, thalidomide, and dexamethasone with or without daratumumab and followed by daratumumab maintenance or observation in transplant-eligible newly diagnosed multiple myeloma: long-term follow-up of the CASSIOPEIA randomised controlled phase 3 trial

Authors: Moreau, Philippe ^*, Hulin, Cyrille, Perrot, Aurore, Arnulf, Bertrand, Belhadj, Karim, Benboubker, Lotfi, Zweegman, Sonja, Caillon, Hélène, Caillot, Denis, Avet-Loiseau, Hervé, Delforge, Michel, Dejoie, Thomas, Facon, Thierry, Sonntag, Cécile, Fontan, Jean, Mohty, Mohamad, Jie, Kon-Siong, Karlin, Lionel, Kuhnowski, Frédérique, Lambert, Jérôme, Leleu, Xavier, Macro, Margaret, Orsini-Piocelle, Frédérique, Roussel, Murielle, Schiano de Colella, Jean Marc, van de Donk, Niels WCJ, Wuillème, Soraya, Broijl, Annemiek, Touzeau, Cyrille, Tiab, Mourad, Marolleau, Jean-Pierre, Meuleman, Nathalie, Vekemans, Marie-Christiane, Westerman, Matthijs, Klein, Saskia K, Levin, Mark-David, Offner, Fritz, Escoffre-Barbe, Martine, Eveillard, Jean-Richard, Garidi, Réda, Hua, Winnie, Wang, Jianping, Tuozzo, Alba, de Boer, Carla, Rowe, Melissa, Vanquickelberghe, Veronique, Carson, Robin, Vermeulen, Jessica, Corre, Jill, Sonneveld, Pieter

Source: In The Lancet Oncology August 2024 25(8):1003-1014

Daratumumab, carfilzomib, lenalidomide, and dexamethasone with tandem transplant for high-risk newly diagnosed myeloma

Authors: Touzeau, Cyrille ^{1, 2, 3, ∗}, Perrot, Aurore ⁴, Hulin, Cyrille ⁵, Manier, Salomon ⁶, Macro, Margaret ⁷, Chretien, Marie-Lorraine ⁸, Karlin, Lionel ⁹, Escoffre, Martine ¹⁰, Jacquet, Caroline ¹¹, Tiab, Mourad ¹², Leleu, Xavier ¹³, Avet-Loiseau, Herve ⁴, Jobert, Alexandra ¹⁴, Planche, Lucie ¹⁴, Corre, Jill ⁴, Moreau, Philippe ^{1, 2, 3}

Source: In Blood 16 May 2024 143(20):2029-2036

Teclistamab Improves Patient-Reported Symptoms and Health-Related Quality of Life in Relapsed or Refractory Multiple Myeloma: Results From the Phase II MajesTEC-1 Study

Authors: Martin, Thomas G., Moreau, Philippe, Usmani, Saad Z., Garfall, Alfred, Mateos, María-Victoria, San-Miguel, Jesús F., Oriol, Albert, Nooka, Ajay K., Rosinol, Laura, Chari, Ajai, Karlin, Lionel, Krishnan, Amrita, Bahlis, Nizar, Popat, Rakesh, Besemer, Britta, Martínez-López, Joaquín, Delforge, Michel, Trancucci, Danielle, Pei, Lixia, Kobos, Rachel, Fastenau, John, Gries, Katharine S., van de Donk, Niels W.C.J.

Source: In Clinical Lymphoma, Myeloma and Leukemia March 2024 24(3):194-202

HLA-DR expression on monocytes and outcome of anti-CD19 CAR T-cell therapy for large B-cell lymphoma

Authors: Bourbon, Estelle ^∗, Sesques, Pierre ^∗, Gossez, Morgane, Tordo, Jérémie, Ferrant, Emmanuelle, Safar, Violaine, Wallet, Florent, Aussedat, Guillaume, Maarek, Alizée, Bouafia, Fadhela, Karlin, Lionel, Ghergus, Dana, Golfier, Camille, Lequeu, Hélène, Lazareth, Anne, Schwiertz, Vérane, Viel, Sébastien, Idlhaj, Maryam, Ghesquières, Hervé, Monneret, Guillaume, Bachy, Emmanuel, Venet, Fabienne

Source: In Blood Advances 14 March 2023 7(5):744-755

Sustained Improvement in Health‐Related Quality of Life in Transplant‐Ineligible Newly Diagnosed Multiple Myeloma Treated With Daratumumab, Lenalidomide, and Dexamethasone: MAIA Final Analysis of Patient‐Reported Outcomes.

Authors: Perrot, Aurore, Facon, Thierry, Plesner, Torben, Usmani, Saad Z., Kumar, Shaji, Bahlis, Nizar J., Hulin, Cyrille, Orlowski, Robert Z., Nahi, Hareth, Mollee, Peter, Ramasamy, Karthik, Roussel, Murielle, Jaccard, Arnaud, Delforge, Michel, Karlin, Lionel, Arnulf, Bertrand, Chari, Ajai, Wang, George, Gupta‐Werner, Niodita, Kaila, Shuchita

Source: European Journal of Haematology; May2025, Vol. 114 Issue 5, p883-889, 7p

Subject Terms: FRAIL elderly, PHYSICAL mobility, MULTIPLE myeloma, FATIGUE (Physiology), LENALIDOMIDE

Oncoral Follow-Up for Outpatients Treated with Oral Anticancer Drugs Assessed by Relative Dose Intensity.

Authors: Larbre, Virginie, Ranchon, Florence, Maucort-Boulch, Delphine, Coz, Elsa, Herledan, Chloé, Caffin, Anne-Gaëlle, Baudouin, Amandine, Maire, Magali, Romain-Scelle, Nicolas, Vacheron, Charles-Hervé, Karlin, Lionel, Salles, Gilles, Ghesquières, Hervé, Rioufol, Catherine

Source: Pharmaceuticals (14248247); Apr2025, Vol. 18 Issue 4, p565, 17p

Subject Terms: TERMINATION of treatment, ORAL medication, HEMATOLOGIC malignancies, ANTINEOPLASTIC agents, NURSING interventions

Real‐World Outcomes of Newly Diagnosed Multiple Myeloma Patients Treated Before the Era of Anti‐CD38 Antibodies: The EMMY Cohort From 2017 to 2020.

Authors: Vincent, Laure, Decaux, Olivier, Perrot, Aurore, Royer, Bruno, Chalopin, Thomas, Bobin, Arthur, Macro, Margaret, Caillot, Denis, Karlin, Lionel, Jacquet, Caroline, Sonntag, Cécile, Mohty, Mohamad, Frenzel, Laurent, Jaccard, Arnaud, Manier, Salomon, Sanhes, Laurence, Chaoui, Driss, Moreau, Philippe, Garlantézec, Ronan, Texier, Nathalie

Source: Cancer Medicine; Mar2025, Vol. 14 Issue 6, p1-16, 16p

Subject Terms: STEM cell transplantation, MULTIPLE myeloma, OVERALL survival, SURVIVAL rate, IMMUNOGLOBULINS

Prediction of venous thromboembolism in patients with multiple myeloma treated with lenalidomide, bortezomib, dexamethasone, and transplantation: Lessons from the substudy of IFM/DFCI 2009 cohort

Authors: Chalayer, Emilie ^*, Talbot, Alexis, Frenzel, Laurent, Karlin, Lionel, Collet, Philippe, Guyotat, Denis, Attal, Michel, Leleu, Xavier, Tardy, Bernard

Source: In Journal of Thrombosis and Haemostasis August 2022 20(8):1859-1867

Bortezomib and high-dose melphalan conditioning regimen in frontline multiple myeloma: an IFM randomized phase 3 study

Authors: Roussel, Murielle ^*, Lauwers-Cances, Valérie, Macro, Margaret, Leleu, Xavier, Royer, Bruno, Hulin, Cyrille, Karlin, Lionel, Perrot, Aurore, Touzeau, Cyrille, Chrétien, Marie-Lorraine, Rigaudeau, Sophie, Dib, Mamoun, Nicolas-Virelizier, Emmanuelle, Escoffre-Barbe, Martine, Belhadj, Karim, Mariette, Clara, Stoppa, Anne-Marie, Araujo, Carla, Doyen, Chantal, Fontan, Jean, Kolb, Brigitte, Garderet, Laurent, Brechignac, Sabine, Malfuson, Jean-Valère, Jaccard, Arnaud, Lenain, Pascal, Borel, Cécile, Hebraud, Benjamin, Benbrahim, Omar, Dorvaux, Véronique, Manier, Salomon, Augeul-Meunier, Karine, Vekemans, Marie-Christiane, Randriamalala, Edouard, Chaoui, Driss, Caers, Jo, Chaleteix, Carine, Benboubker, Lofti, Vincent, Laure, Glaisner, Sylvie, Zunic, Patricia, Slama, Borhane, Eveillard, Jean-Richard, Humbrecht-Kraut, Catherine, Morel, Véronique, Mineur, Philippe, Eisenmann, Jean-Claude, Demarquette, Hélène, Richez, Valentine, Vignon, Marguerite, Caillot, Denis, Facon, Thierry, Moreau, Philippe, Colin, Anne-Laurène, Olivier, Pascale, Wuilleme, Soraya, Avet-Loiseau, Hervé, Corre, Jill, Attal, Michel

Source: In Blood 5 May 2022 139(18):2747-2757

Melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide (OCEAN): a randomised, head-to-head, open-label, phase 3 study

Authors: Schjesvold, Fredrik, Delimpasi, Sosana, Robak, Pawel, Coriu, Daniel, Nikolayeva, Anna, Tomczak, Waldemar, Pour, Ludek, Spicka, Ivan, Dimopoulos, Meletios-Athanasios, Masszi, Tamas, Doronin, Vadim, Minarik, Jiri, Salogub, Galina, Alekseeva, Yulia, Maisnar, Vladimir, Mikala, Gabor, Rosinol, Laura, Konstantinova, Tatiana, Lazzaro, Antonio, Liberati, Anna Marina, Symeonidis, Anargyros, Gatt, Moshe, Illes, Arpad, Abdulhaq, Haifaa, Dungarwalla, Moez, Grosicki, Sebastian, Hajek, Roman, Leleu, Xavier, Myasnikov, Alexander, Richardson, Paul G., Avivi, Irit, Deeren, Dries, Gironella, Mercedes, Hernandez-Garcia, Miguel Teodoro, Martinez Lopez, Joaquin, Newinger-Porte, Muriel, Ribas, Paz, Samoilova, Olga, Voog, Eric, Arnao-Herraiz, Mario, Carrillo-Cruz, Estrella, Corradini, Paolo, Dodlapati, Jyothi, Granell Gorrochategui, Miquel, Huang, Shang-Yi, Jenner, Matthew, Karlin, Lionel, Kim, Jin Seok, Kopacz, Agnieszka, Medvedeva, Nadezhda, Min, Chang-Ki, Mina, Roberto, Palk, Katrin, Shin, Ho-Jin, Sohn, Sang Kyun, Sonneveld, Pieter, Tache, Jason, Anagnostopoulos, Achilles, Arguiñano, Jose-Maria, Cavo, Michele, Filicko, Joanne, Garnes, Margaret, Halka, Janusz, Herzog-Tzarfati, Kathrin, Ipatova, Natalia, Kim, Kihyun, Krauth, Maria-Theresa, Kryuchkova, Irina, Lazaroiu, Mihaela Cornelia, Luppi, Mario, Proydakov, Andrei, Rambaldi, Alessandro, Rudzianskiene, Milda, Yeh, Su-Peng, Alcalá-Peña, Maria Magdalena, Alegre Amor, Adrian, Alizadeh, Hussain, Bendandi, Maurizio, Brearton, Gillian, Brown, Randall, Cavet, Jim, Dally, Najib, Egyed, Miklos, Hernández-Rivas, José Ángel, Kaare, Ain, Karsenti, Jean-Michel, Kloczko, Janusz, Kreisle, William, Lee, Je-Jung, Legiec, Wojciech, Machherndl-Spandl, Sigrid, Manda, Sudhir, Mateos, Maria-Victoria, Moiseev, Ivan, Moreb, Jan, Nagy, Zsolt, Nair, Santosh, Oriol-Rocafiguera, Albert, Osswald, Michael, Otero-Rodriguez, Paula, Peceliunas, Valdas, Plesner, Torben, Rey, Philippe, Rossi, Giuseppe, Stevens, Don, Suriu, Celia, Tarella, Corrado, Verlinden, Anke, Zannetti, Alain, Schjesvold, Fredrik H ^*, Pour, Luděk, Špička, Ivan, Mikala, Gábor, Rosiñol, Laura, Symeonidis, Argiris, Moody, Victoria, Thuresson, Marcus, Byrne, Catriona, Harmenberg, Johan, Bakker, Nicolaas A, Hájek, Roman, Richardson, Paul G

Source: In The Lancet Haematology February 2022 9(2):e98-e110

Maintenance with daratumumab or observation following treatment with bortezomib, thalidomide, and dexamethasone with or without daratumumab and autologous stem-cell transplant in patients with newly diagnosed multiple myeloma (CASSIOPEIA): an open-label, randomised, phase 3 trial

Authors: Moreau, Philippe ^*, Hulin, Cyrille, Perrot, Aurore, Arnulf, Bertrand, Belhadj, Karim, Benboubker, Lotfi, Béné, Marie C, Zweegman, Sonja, Caillon, Hélène, Caillot, Denis, Corre, Jill, Delforge, Michel, Dejoie, Thomas, Doyen, Chantal, Facon, Thierry, Sonntag, Cécile, Fontan, Jean, Mohty, Mohamad, Jie, Kon-Siong, Karlin, Lionel, Kuhnowski, Frédérique, Lambert, Jérôme, Leleu, Xavier, Macro, Margaret, Orsini-Piocelle, Frédérique, Roussel, Murielle, Stoppa, Anne-Marie, van de Donk, Niels W C J, Wuillème, Soraya, Broijl, Annemiek, Touzeau, Cyrille, Tiab, Mourad, Marolleau, Jean-Pierre, Meuleman, Nathalie, Vekemans, Marie-Christiane, Westerman, Matthijs, Klein, Saskia K, Levin, Mark-David, Offner, Fritz, Escoffre-Barbe, Martine, Eveillard, Jean-Richard, Garidi, Réda, Ahmadi, Tahamtan, Krevvata, Maria, Zhang, Ke, de Boer, Carla, Vara, Sanjay, Kampfenkel, Tobias, Vanquickelberghe, Veronique, Vermeulen, Jessica, Avet-Loiseau, Hervé, Sonneveld, Pieter

Source: In The Lancet Oncology October 2021 22(10):1378-1390

Clinicopathological features and survival in EBV-positive diffuse large B-cell lymphoma not otherwise specified

Authors: Bourbon, Estelle, Maucort-Boulch, Delphine, Fontaine, Juliette, Mauduit, Claire, Sesques, Pierre, Safar, Violaine, Ferrant, Emmanuelle, Golfier, Camille, Ghergus, Dana, Karlin, Lionel, Lazareth, Anne, Bouafia, Fadhela, Pica, Gian Matteo, Orsini-Piocelle, Frédérique, Rocher, Clément, Gros, François-Xavier, Parrens, Marie, Dony, Arthur, Rossi, Cédric, Ghesquières, Hervé, Bachy, Emmanuel, Traverse-Glehen, Alexandra ^*, Sarkozy, Clémentine ^{*, *}

Source: In Blood Advances 24 August 2021 5(16):3227-3239

Teclistamab, a B-cell maturation antigen × CD3 bispecific antibody, in patients with relapsed or refractory multiple myeloma (MajesTEC-1): a multicentre, open-label, single-arm, phase 1 study

Authors: Usmani, Saad Z ^*, Garfall, Alfred L, van de Donk, Niels W C J, Nahi, Hareth, San-Miguel, Jesus F, Oriol, Albert, Rosinol, Laura, Chari, Ajai, Bhutani, Manisha, Karlin, Lionel, Benboubker, Lotfi, Pei, Lixia, Verona, Raluca, Girgis, Suzette, Stephenson, Tara, Elsayed, Yusri, Infante, Jeffrey, Goldberg, Jenna D, Banerjee, Arnob, Mateos, María-Victoria, Krishnan, Amrita

Source: In The Lancet 21-27 August 2021 398(10301):665-674

Oral ixazomib, lenalidomide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma

Authors: Facon, Thierry ^*, Venner, Christopher P., Bahlis, Nizar J., Offner, Fritz, White, Darrell J., Karlin, Lionel, Benboubker, Lotfi, Rigaudeau, Sophie, Rodon, Philippe, Voog, Eric, Yoon, Sung-Soo, Suzuki, Kenshi, Shibayama, Hirohiko, Zhang, Xiaoquan, Twumasi-Ankrah, Philip, Yung, Godwin, Rifkin, Robert M., Moreau, Philippe, Lonial, Sagar, Kumar, Shaji K., Richardson, Paul G., Rajkumar, S. Vincent

Source: In Blood 1 July 2021 137(26):3616-3628

Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial

Authors: Moreau, Philippe, Dimopoulos, Meletios-Athanasios, Mikhael, Joseph, Yong, Kwee, Capra, Marcelo, Facon, Thierry, Hajek, Roman, Spicka, Ivan, Baker, Ross, Kihyun, Kim, Martinez, Gracia, Chang-Ki, Min, Pour, Ludek, Leleu, Xavier, Oriol, Albert, Youngil, Koh, Suzuki, Kenshi, Martin, Tom, Quach, Hang, Lim, Andrew, Crowther, Helen, Sia, Hanlon, Hulin, Cyrille, Mohty, Mohamad, Mikala, Gabor, Nagy, Zsolt, Reinoso Segura, Marta, Rosinol, Laura, Yagci, Munci, Turgut, Mehmet, Garg, Mamta, Parmar, Gurdeep, Augustson, Brad, Castro, Nelson, Crusoe, Edvan, Pika, Tomas, Delimpasi, Sosana, Ishizawa, Kenichi, George, Anup, Konstantinova, Tatiana, De La Rubia, Javier, Sung-Hyun, Kim, Maiolino, Angelo, Reiman, Anthony, LeBlanc, Richard, Ito, Shigeki, Tanaka, Junji, Luchinin, Alexander, Kryuchkova, Irina, Martinez, Joaquin, Shustik, Jesse, Karlin, Lionel, Symeonidis, Anargyros, Egyed, Miklos, Petrini, Mario, Cavo, Michele, Uchiyama, Michihiro, Blacklock, Hilary, Arat, Mutlu, Griffin, James, Hunter, Hannah, Buck, Tonda, Anagnostopoulos, Achilles, Konstantopoulos, Konstantinos, Masszi, Tamas, Bringhen, Sara, Gamberi, Barbara, Kawano, Yawara, Jin Seok, Kim, Ozdogu, Hakan, Ozkalemkas, Fahir, Špička, Ivan, Kim, Kihyun, Min, Chang-Ki, Koh, Youngil, Risse, Marie-Laure, Asset, Gaelle, Macé, Sandrine, Martin, Thomas ^*

Source: In The Lancet 19-25 June 2021 397(10292):2361-2371

Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial

Authors: Alegre Amor, Adrian, Baldini, Luca, Beksac, Meral, Belotti, Angelo, Benboubker, Lotfi, Besemer, Britta, Besisik, Sevgi, Bila, Jelena, Boccadoro, Mario, Cavo, Michele, De La Rubia Comos, Javier, Delimpasi, Sosana, Dimopoulos, Meletios A., Doyen, Chantal, Dytfeld, Dominik, Engelhardt, Monika, Facon, Thierry, Foà, Roberto, Goldschmidt, Hartmut, Grosicki, Sebastian, Hajek, Roman, Hayri Ozsan, Guner, Hulin, Cyrille, Iversen, Brian, Karlin, Lionel, Katodritou, Eirini, Knop, Stefan, Kyrtsonis, Marie-Christine, Lahuerta, Juan Jose, Leleu, Xavier, Martinez Chamorro, Carmen, Mateos Manteca, María-Victoria, Meuleman, Nathalie, Minnema, Monique, Moreau, Philippe, Offidani, Massino, Oriol Rocafiguera, Albert, Pehlivan, Mustafa, Pour, Ludek, Roerdink, Henk Th.J., Rosinol Dacsh, Laura, Salwender, Hans, Sonneveld, Pieter, Symeonidis, Anargyros, Toftmann Hansen, Charlotte, Tuglular, Tulin, Unal, Ali, Vlummens, Philip, Vural, Filiz, Wu, Ka Lung, Zweegman, Sonja, Dimopoulos, Meletios A ^*, Terpos, Evangelos, Symeonidis, Argiris, Oriol, Albert, Mateos, Maria-Victoria, Einsele, Hermann, Orfanidis, Ioannis, Ahmadi, Tahamtan, Ukropec, Jon, Kampfenkel, Tobias, Schecter, Jordan M, Qiu, Yanping, Amin, Himal, Vermeulen, Jessica, Carson, Robin

Source: In The Lancet Oncology June 2021 22(6):801-812